Search NEL Online

Comparative Study 2010; 31(1): 147-154 PubMed PMID: 20150876 Citation  Keywords:  Acromegaly:etiology, Adenoma:complications, Adult, Female, GTP-Binding Protein alpha Subunits:genetics, Ghrelin:genetics, Growth Hormone-Secreting Pituitary Adenoma:complications, Humans, Male, Middle Aged, Mutation, RNA, Messenger:metabolism, Receptors, .   

OBJECTIVE: The purpose of this study was to investigate the relationship between the ghrelin or GHSR-1a mRNA levels and clinical characteristics and to confirm the effect of gsp mutations on ghrelin/GHSR-1a system in human GH-secreting pituitary adenomas.

METHODS: The expression levels of ghrelin, GHSR-1a mRNA were determined by SYBR green real-time fluorescent quantitative PCR. The gsp mutations in 43 cases of human GH-secreting pituitary adenomas were detected using PCR-DNA direct sequencing analysis. Clinical data were obtained from the medical records of 43 acromegalic patients who had GH and IGF-1 assays in the same laboratory.

RESULTS: The expression of GHSR-1a correlated positvely with tumor size (R=0.411, p=0.006) and invasiveness (p<0.05). In contrast, ghrelin mRNA levels correlated positively only with tumor size (R=0.331, p=0.030) but not with tumor invasiveness (p>0.05). The expression level of GHSR-1a mRNA was significantly higher in gsp positive adenomas than in negative adenomas (p<0.05). Whereas, there was no significant difference in the expression of ghrelin mRNA between gsp mutation-positive and -negative adenomas (p>0.05). Additionally there was a significant positve correlation between the ghrelin and GHSR-1a mRNA expression levels in gsp-positive (R=0.553, p=0.040) or -negative adenomas (R=0.489, p=0.007).

CONCLUSIONS: GHSR-1a correlated positively with tumor size and invasiveness, while ghrelin correlated positively only with tumor size. Gsp mutations may upregulate the expression of GHSR-1a mRNA and have no effect on ghrelin mRNA levels in human GH-secreting pituitary adenomas....

Read abstract  Full text PDF

Case Reports 2010; 31(1): 43-46 PubMed PMID: 20150875 Citation  Keywords:  Abnormalities, Multiple:diagnosis, Child, Chromosomes, Human, Pair 18, Developmental Disabilities:diagnosis, Female, Humans, Syndrome, Trisomy:diagnosis,.   

: Trisomy 18 (Edwards syndrome - ES) is the second most common trisomy. It occurs in 1/3 000 to 1/8 000 births. ES is a cause of numerous developmental disorders and malformations. The median life span of children with ES is about 2 weeks and only 5%-10% will survive their first year of life. The report presents a case of a 6-year-old girl with ES....

Read abstract  Full text PDF

Journal Article 2010; 31(1): 67-72 PubMed PMID: 20150874 Citation  Keywords:  Animals, Animals, Genetically Modified, Cell Proliferation:drug effects, Chick Embryo:metabolism, Down-Regulation:drug effects, Embryonic Development:drug effects, Ganglia, Spinal:drug effects, Gene Expression Regulation, Developmental:drug effects, Gene .   

OBJECTIVE: Protein Isl-1 RNA interference and over expression in early chicken embryo dorsal root ganglia (DRG) were used to investigate the function of Isl-1 in DRG cell proliferation.

METHODS: Isl-1 targeted shRNA expression vector and Isl-1 over-expression vector were transfected into chicken embryo DRG by in ovo electroporation. Then, the DRG proliferation rate was detected by BrdU immunohistochemistry.

RESULTS: The rate of DRG cell proliferation increased after Isl-1 knock-down and decreased after Isl-1 over-expression.

CONCLUSIONS: In this study, we found that Isl-1 negatively modulates DRG cell proliferation....

Read abstract  Full text PDF

Journal Article 2010; 31(1): 117-121 PubMed PMID: 20150873 Citation  Keywords:  Adult, Autistic Disorder:urine, Brief Psychiatric Rating Scale, Bufotenin:analysis, Case-Control Studies, Chromatography, High Pressure Liquid, Female, Humans, Male, Mass Spectrometry, Research Design, Schizophrenia:urine, Up-Regulation, Young Adult,.   

OBJECTIVE: Previous studies have suggested that the endogeneous psychotomimetic molecule bufotenine (N-N-dimethyl-5-idroxytryptamine) may play a role in the pathogenesis of severe mental disorders. The potential association of bufotenine with the clinical features of autism and schizophrenia is not entirely understood. In this study, we measured urinary levels of bufotenine in subjects with autistic spectrum disorder (ASD), schizophrenia and healthy comparison subjects free of psychiatric symptoms. We also sought to assess whether urine concentrations of this molecule may be associated with the clinical characteristics of psychiatric patients.

DESIGN: Urine bufotenine levels were measured using a high-performance liquid chromatography-mass spectrometry (HPLC-MS) assay in young adults with severe ASD (n=15), patients with schizophrenia (n=15), and healthy control subjects (n=18). The Vineland Adaptive Behavior Scale was used to measure adaptive behaviors in ASD individuals. The Brief Psychiatric Rating Scale (BPRS) was used for patients with schizophrenia.

RESULTS: Urine bufotenine levels were significantly higher in ASD subjects (3.30 +/- 0.49 microg/L, p<0.05) and patients with schizophrenia (4.39 +/- 0.43 microg/L, p<0.001) compared with controls (1.53 +/- 0.30 microg/L). Among patients with ASD, there was a significant positive correlation between urine bufotenine and hyperactivity scores on the Vineland Adaptive Behavior Scale (r=0.479, p<0.05). No other associations were detected.

CONCLUSIONS: Our results indicate that elevated urine levels of the endogeneous psychotomimetic molecule bufotenine may play a role in ASD and schizophrenia, and can be correlated with hyperactivity scores in autism....

Read abstract  Full text PDF

Journal Article 2010; 31(1): 11-18 PubMed PMID: 20150871 Citation  Keywords:  Cannabinoid Receptor Modulators:biosynthesis, Catechol O-Methyltransferase:genetics, Cytochrome P-450 CYP2D6:genetics, Enzymes:genetics, Genetic Predisposition to Disease, Health, Humans, Mental Disorders:genetics, Metabolic Networks and Pathways:genetics.   

: Endogenous morphine has been detected in human tissues from the vascular, immune and nervous systems. The genes/enzymes (CYP2D6, COMT and PNMT) that are involved in the biosynthesis of morphine have variations that affect their functionality. Some of these variations are the result of single nucleotide polymorphisms of DNA sequences. This review highlights some of the functional differences in the critical enzymes required for the biosynthesis of morphine that may affect human health. These variations have been shown to change the way animals react to stressors, perceive pain and behave. The presence of morphine signaling in almost all organ systems suggests that it is most likely playing a role in maintaining the health and promoting the normal functioning of these physiological systems....

Read abstract  Full text PDF

Journal Article 2010; 31(1): 87-91 PubMed PMID: 20150870 Citation  Keywords:  Animals, Antidiuretic Agents:administration & dosage, Ascorbic Acid:administration & dosage, Central Nervous System:drug effects, Consciousness, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Injections, Intraventricular, Male, Natriuresi.   

OBJECTIVE: Ascorbic acid represents one of the most important antioxidants and neuromodulators, and plays an important role in the cerebral system. In the present study, we investigated the central effect of ascorbic acid on fluid regulation and electrolyte homeostasis.

METHODS: Male Wistar rats were implanted with stainless steel cannulas into the lateral ventricle, and sodiun excretion and urinary volume were measured after intracerebroventricular (i.c.v.) injection of ascorbic acid (200 or 600 nmol/rat). In another set of experiments, vasopressin and oxytocin plasma levels were evaluated 10, 20 and 30 minutes after ascorbic acid i.c.v. injection.

RESULTS: The administration of ascorbic acid to conscious rats resulted in a significant decrease in urinary volume and an increase in the renal excretion of sodium, with a concomitant increase in the plasma levels of vasopressin and oxytocin.

CONCLUSIONS: These results suggest that ascorbic acid may play a significant role in the central regulation of fluid and electrolyte homeostasis....

Read abstract  Full text PDF

Journal Article 2010; 31(1): 63-66 PubMed PMID: 20150869 Citation  Keywords:  Case-Control Studies, Cystinyl Aminopeptidase:blood, Down-Regulation, Enzyme Activation, Female, Gestational Age, Humans, Pre-Eclampsia:blood, Pregnancy, Premature Birth:blood, Severity of Illness Index, Term Birth:blood,.   

OBJECTIVE: Placental Leucine Aminopeptiadse (P-LAP) also known as oxytocinase, is secreted by syncytiotrophoblast and increases gradually during pregnancy until delivery. It is a regulator of uterine contractions, of vascular resistance and of volume of the retroplacental blood pool. Recently, it was shown that it could also regulate metalloproteinase 9 activity and thus, invasiveness of trophoblastic cells. Since development of preeclampsia could be initiated by decreased cytotrophoblastic invasion of spiral arterioles and a reduced uteroplacental perfusion, we speculate that circulating P-LAP activity could be decreased during preeclampsia.

MATERIALS AND METHODS: Case-control study was evaluated in 84 women. P-LAP activity was measured in n=51 healthy pregnant women at term, and compared with n=16 normotensive women delivering preterm and n=17 women diagnosed with pre-eclampsia. P-LAP activity was determined by colorimetry in plasma samples using L-Leucine-p-nitroanilide as substrate.

RESULTS: P-LAP activity was significantly lower in sera of preeclamptic women (0.91+/-0.122 mDO/min) as compared to normotensive controls (1.41+/-0.103 mDO/min; p=0.003) irrespective of time of delivery.

CONCLUSIONS: These findings confirm the probable involvement of P-LAP in trophoblast invasion and development of preeclampsia....

Read abstract  Full text PDF

Journal Article 2010; 31(1): 155-160 PubMed PMID: 20150868 Citation  Keywords:  Aged, Aged, 80 and over, Biomarkers:analysis, Body Mass Index, Bone Density, Bone Remodeling:physiology, Bone and Bones:metabolism, Calcium:analysis, Female, Humans, Leptin:blood, Male, Middle Aged, Osteoporosis:blood,.   

OBJECTIVE: Clinical data have suggested that obesity protects against osteoporosis. Leptin, mainly secreted by white adipose tissue, might be involved by mediating an effect on bone metabolism. This study was conducted to investigate a possible relationship of leptin and bone turn-over in postmenopausal women with osteoporosis.

METHODS: We measured bone mineral density (BMD), serum leptin levels and markers of bone metabolism, including osteocalcin and cross-laps in 44 patients with osteoporosis. The main group consisted of 32 postmenopausal women.

RESULTS: Mean serum leptin was 13.1 microg/L and showed no statistically significant difference to the levels measured in a collective of normal persons adjusted for age and BMI. When related to serum cross-laps as markers of bone resorption, a positive correlation (p<0.05) was observed, whereas no correlation with osteocalcin could be seen.

CONCLUSIONS: A dual control of bone formation by leptin is assumed: This involves local mechanisms acting on osteoblasts and a central inhibitory effect on bone metabolism via a hypothalamic relay. Our data indicate that the net effect of circulating leptin may cause bone loss and is significantly related to high-turnover serum bone markers, at least in postmenopausal women with osteoporosis....

Read abstract  Full text PDF